Centre signs deal to get 2nd made-in-India COVID-19 vaccine, books 30 crore doses

by National | 03-06-2021 | 11217 views

NewDelhi: The Centre on Thursday announced it has finalised arrangements with Hyderabad-based vaccine manufacturer Biological E to reserve 30 crore of its COVID-19 vaccine doses, the second made-in-India vaccine after Bharat Biotech's Covaxin. The Centre would be making an advance payment of ₹1,500 crore to Biological E. These vaccine doses will be manufactured and stockpiled from August-December 2021.

India has reported 1,34,154 new COVID-19 cases and 2,887 deaths in the last 24 hours, as per the Union Health Ministry. This comes a day after the country reported 3,207 COVID-19 deaths. With this, the total number of cases reached 2,84,41,986, while the death toll surged to 3,37,989.

As many as 307 deaths due to coronavirus were reported in Bengaluru in the last 24 hours. This is the first time after seven days that the Karnataka capital reported more than 300 coronavirus deaths. Further, the daily cases crossed the 4,000-mark again as 4,095 people tested positive for the virus in Bengaluru.

India's COVID-19 vaccination drive crosses 22-crore mark

The total number of beneficiaries during India's COVID-19 vaccination drive crossed the 22-crore mark on Wednesday which was the 138th day of the drive. As many as 11,37,597 beneficiaries of the 18-44 age group got their first dose and 19,523 beneficiaries of the same age group received their second dose. In the last 24 hours, 24,26,265 people received COVID-19 vaccines.

Lets socialize : Share via Whatsapp